Welcome to Regeneus
Regeneus Ltd (ASX: RGS) is an Australian clinical-stage regenerative medicine company developing a portfolio of innovative cellular therapies targeting significant unmet medical needs with a licence driven strategy.
Our initial focus is on osteoarthritis and other inflammatory conditions, cancer, inflammatory skin conditions and wound healing. Our allogeneic stem cell and secretions technologies have the ability to be clinically developed to treat multiple indications.
The Company’s product pipeline is underpinned by proprietary stem cell and immuno-oncology technologies.